Bispecific VH/Fab antibodies targeting neutralizing and non-neutralizing Spike epitopes demonstrate enhanced potency against SARS-CoV-2

Numerous neutralizing antibodies that target SARS-CoV-2 have been reported, and most directly block binding of the viral Spike receptor-binding domain (RBD) to angiotensin-converting enzyme II (ACE2). Here, we deliberately exploit non-neutralizing RBD antibodies, showing they can dramatically assist...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Shion A. Lim, Josef A. Gramespacher, Katarina Pance, Nicholas J. Rettko, Paige Solomon, Jing Jin, Irene Lui, Susanna K. Elledge, Jia Liu, Colton J. Bracken, Graham Simmons, Xin X. Zhou, Kevin K. Leung, James A. Wells
Format: Artigo
Langue:Inglês
Publié: Taylor & Francis Group 2021-01-01
Collection:mAbs
Sujets:
Bispecific
neutralizing antibody
knob-in-hole
COVID-19
SARS-CoV-2
Accès en ligne:https://www.tandfonline.com/doi/10.1080/19420862.2021.1893426
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires